HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

888.238

-1.846-0.21%

Number of Gainers:7

Number of Losers:3

Number of Flat:3

PE:- -

High:891.531

Open:889.747

Low:879.542

Close:890.084

Volume:36.86M

Turnover:396.29M

Market Cap:148.45B

Float Cap:108.83B

Loading ...

3SBio Files HKEX Next-Day Disclosure Return Reporting Share Repurchase

HAOHAI BIOTEC Spends Approximately HK$795,700 on Share Buyback

AH Share Premium Rankings: September 10 Market Close Update

Pharmaceutical Firms Divest Assets to Bolster Core Operations

Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials

Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9

CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against Rabies, Issued in China

Sinopharm Group Stock Slips 2.1% in Hong Kong

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

HAOHAI BIOTEC (06826) Spends HK$529,300 to Buy Back 31,500 Shares on September 8

Shanghai Fosun Pharma - Receives Nmpa Approval for Phase Ii/Iii Clinical Trial of Fxs5626

THOMSON REUTERS

Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication

Fosun Pharma Spends HK$1.18M on Share Buyback on September 7

Sinopharm Group Stock Rallies 0.9% in Hong Kong

Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%

MT Newswires Live

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares

THOMSON REUTERS

Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale

Sisram Medical Declares HKD 0.095 Final Dividend for Fy2025

Sinopharm Group Stock Advances 1.5% in Hong Kong

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1593/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":888.238,"timestamp":1789546124622,"preClose":890.084,"halted":0,"volume":36860308,"delay":0,"changeRate":-0.002074,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-1.846008,"latestTime":"09-16 16:00:00","open":889.7474,"high":891.53107,"low":879.5415,"amount":396294432,"amplitude":0.01347,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":1.136925,"peRate":10.390002,"turnoverRate":0.001796,"increases":6,"decrements":4,"flats":3,"marketCap":148453874624,"floatMarketCap":108833429952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":891.53107,"amplitude":0.01347,"preClose":890.084,"low":879.5415,"pbRate":"1.136925","latestPrice":888.238,"volume":36860308,"delay":0,"open":889.7474,"prevYearClose":1094.978,"prevWeekClose":869.902,"prevMonthClose":902.195,"prevQuarterClose":846.145,"fiveDayClose":916.041,"twentyDayClose":932.26,"sixtyDayClose":841.364,"secType":"PLATE","market":"HK","turnoverRate":0.001796,"peRate":10.390002,"marketCap":148453874624,"floatMarketCap":108833429952,"timestamp":1789546124622,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":7,"down":3,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666673685","title":"3SBio Files HKEX Next-Day Disclosure Return Reporting Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2666673685","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666673685?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:36","pubTimestamp":1789036581,"startTime":"0","endTime":"0","summary":"3SBio files HKEX next-day disclosure return reporting share repurchase3SBio repurchased 4,000,000 ordinary shares on Sept. 10, 2026, holding them as treasury shares.Buyback range HKD 15.5 to HKD 15.75","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL4fyG9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1583","BK1593","BK1161","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117842310","title":"HAOHAI BIOTEC Spends Approximately HK$795,700 on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1117842310","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117842310?lang=en_us&edition=fundamental","pubTime":"2026-09-10 17:44","pubTimestamp":1789033451,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (06826) announced that on September 10, 2026, it utilized approximately HK$795,700 to repurchase 48,000 shares of the company.The buyback transaction reflects the company's ongoing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120089169","title":"AH Share Premium Rankings: September 10 Market Close Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1120089169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120089169?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:23","pubTimestamp":1789028611,"startTime":"0","endTime":"0","summary":"As of the market close on September 10, data reveals the latest rankings for A-H share premium ratios, with NE Electric (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) claiming the top...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1554","HK0000352291.HKD","03130","IE00B29SXG58.USD","LU0862451753.SGD","LU1807302812.USD","LU0345780521.USD","LU0320764755.SGD","BK1148","LU0880133367.SGD","SG9999002463.SGD","LU0531971595.HKD","02218","IE00B3M56506.USD","HK0000320264.USD","LU0417516738.SGD","LU0588546209.SGD","00187","BK1564","03188","LU2394011477.USD","01033","LU1023057109.AUD","BK1574","IE00BVYPNQ40.USD","BK1551","LU0348766576.USD","LU1675838814.USD","LU2778985437.USD","LU0469268626.HKD","LU0049853897.USD","BK1592","02827","LU2177674079.SGD","SG9999004220.SGD","IE00BYV24P56.USD","LU1303224171.USD","BK1198","LU0287142896.SGD","BK1249","06185","BK1506","BK1507","LU1211504680.USD","BK1147","LU0672654166.SGD","83188","BK1170","LU1244550221.USD","BK1514","LU2097828631.EUR","BK1593","IE00BF5LJ272.USD","LU1152091168.USD","SG9999001093.SGD","IE0032431581.USD","LU2039709279.SGD","LU0214875030.USD","LU1224709979.USD","BK1521","LU0052750758.USD","LU2294711473.HKD","LU1770034418.SGD","06826","03200","LU0228659784.USD","BK1515","BK1163","01349","00300","BK1533","LU0082770016.USD","LU0828238088.HKD","LU0061477393.USD","BK1144","HK0000306701.USD","BK1522","159982","LU0327786744.USD","LU1244550494.USD","LU0348816934.USD","LU1481107354.HKD","BK1110","LU0561508036.HKD","02068","LU0082770016.SGD","LU0456854461.SGD","LU0543330566.HKD","BK1141","IE00B031J352.USD","BK1214","LU0163747925.USD","LU2399975544.HKD","LU1242518857.USD","LU1961090484.USD","LU2097828474.EUR","LU1769817096.USD","LU0648948544.HKD","LU0502904849.HKD","IE0008369823.USD","LU0329678170.USD","03750","BK1183","LU0315179316.USD","BK1202","IE00BVYPNP33.GBP","BK1223","LU1880383366.USD","LU0620787316.HKD","BK1191","LU0791590937.USD","LU0359201612.USD","LU0211977185.USD","399300","LU0348825331.USD","IE00BGHQDM52.EUR","LU0828237510.HKD","LU0540923850.HKD","LU1282649067.USD","LU2476274308.USD","LU0501845795.SGD","LU0456846285.SGD","LU1993786604.SGD","LU1046422090.SGD","LU0173614495.USD","LU0165289439.USD","02338","LU0067412154.USD","BK1560","BK1125","LU1504937902.USD","LU0890818403.SGD","LU1366334651.USD","LU0140636845.USD","LU0370786039.SGD","BK1610","LU0359201885.HKD","LU0979878070.USD","82846","IE0008368742.USD","LU0640798160.USD","SG9999011746.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","00317","LU0828237940.HKD","LU1282649810.SGD","LU0488056044.USD","LU0051755006.USD","LU0254981946.USD","LU0531970944.HKD","LU0096374516.USD","LU1831875114.USD","LU0039217434.USD","LU0348788117.USD","LU0737861772.HKD","BK1149","LU0048580855.USD","LU2045819591.USD","LU2226246903.HKD","LU0348805143.USD","01057","LU0516422440.USD","LU0871576103.HKD","LU0348827113.USD","LU1794554557.SGD","BK1583","LU0509642566.USD","00991","LU1064131342.USD","LU0593848301.USD","LU0307460666.USD","BK1576","LU1152091754.HKD","LU0918141705.HKD","LU2097828557.USD","01108","IE00BMCWC346.EUR","LU0329678337.USD","BK1190","HK0000320223.HKD","HK0001040168.HKD","LU0149534421.HKD","LU0516422952.EUR","LU0231483743.USD","LU0868486357.SGD","LU0886674414.USD","06745","LU0634319403.HKD","SG9999014674.SGD","IE00BZ08YT58.USD","LU1048596156.SGD","IE00B031HY20.USD","LU1960683339.HKD","BK1594","83130","LU0266512127.USD","LU0345780281.USD","00895","IE0034224299.USD","LU1282648689.USD","BK1562","LU0269904917.USD","LU0572944931.SGD","LU0128522157.USD","06869","07233","LU0117841782.USD","IE00B543WZ88.USD","SG9999006597.SGD","BK1116","LU0359202008.SGD","SG9999001226.SGD","LU0823426480.USD","03308","LU0164939612.USD","BK1140","00553","BK1544","BK1122","LU0823426308.USD","LU0229945570.USD","LU0210526637.USD","BK1546","EWH","LU0791591158.USD","LU0348735423.USD","LU1282649141.HKD","LU1115378108.SGD","LU0266512473.USD","LU0149721374.USD","HK0001040143.USD","02475","LU0918141887.USD","LU0228367735.SGD","LU1105468828.SGD","LU1688375341.USD","LU0043850808.USD","03328","SG9999002828.SGD","LU0516423174.USD","LU0431992006.USD","LU0106252389.USD","LU0456827905.SGD","BK1161","LU0164880469.USD","02846","LU0463099449.HKD","02359","LU1188198961.HKD","01877","LU1880383440.USD","LU1808992512.USD","IE00B0169L03.USD","LU0543330483.HKD","01812","LU1255011170.USD","LU1251922891.USD","LU0328353924.USD","BK1231","LU0348767384.USD","BK1237","LU1813983027.USD","LU0449509016.USD","06066","LU1720050803.USD","LU0314109678.HKD","LU1244550577.SGD","LU0516423091.SGD","03143","BK1530","LU1366334578.USD","LU0589944569.HKD","BK1523","LU0797268264.HKD","LU1242518931.SGD","LU2125910500.SGD","BK1537","BK1505","LU0106959298.USD","LU0244354667.USD","LU0029875118.USD","LU0417516902.SGD","LU0072913022.USD","IE0031814852.USD","BK1171","LU1328277881.USD","LU0348814723.USD","LU2008162690.USD","LU0164865239.USD","LU0737861699.HKD","LU0181495838.USD","BK1552","03968","LU2476274720.SGD","LU0607220059.USD","03678","HK0000306685.HKD","LU1769817179.HKD","06821","LU0384037296.USD","03986","02865","BK1105","LU0708995583.HKD","LU2097828805.USD","LU2242644610.SGD","02899","LU1655091616.SGD","LU0821914370.USD","LU0516422366.SGD","HK0000352382.USD","LU1719994722.HKD","IE00BZ08YR35.GBP","LU2097828714.EUR","LU3063872942.SGD","LU0320764599.SGD","LU1206782309.USD","LU0326950275.SGD","LU0455707207.USD","LU1988902786.USD","LU2264538146.SGD","LU1008478684.HKD","00042","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169429326","title":"Pharmaceutical Firms Divest Assets to Bolster Core Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1169429326","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169429326?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:12","pubTimestamp":1788966731,"startTime":"0","endTime":"0","summary":"A growing number of domestic listed pharmaceutical companies have recently disclosed asset disposal announcements, planning to sell partial or full equity stakes in their controlled subsidiaries....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","BK1593","BK1161","BK4202","02196","09939","FOSL","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108076077","title":"Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1108076077","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108076077?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:21","pubTimestamp":1788956512,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. has announced that its oral candidate FXS5626 tablets (formerly project code AC-201) have received clinical trial approval from the National Medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0175","BK0196","BK1191","BK1515","600196","BK0183","02196","BK0012","BK0060","BK0096","BK0187","BK0188","BK0028","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156059034","title":"Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1156059034","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156059034?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:06","pubTimestamp":1788948375,"startTime":"0","endTime":"0","summary":"Fosun Pharma (02196) has announced that on September 9, 2026, the company repurchased 152,500 shares for a total consideration of HK$2.63 million.The buyback transaction was disclosed in an official...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0187","BK1515","BK0012","600196","BK0196","BK0175","BK0096","BK0239","BK0188","02196","BK1593","BK0183","BK1191","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666581721","title":"CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against Rabies, Issued in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666581721","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666581721?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:41","pubTimestamp":1788946860,"startTime":"0","endTime":"0","summary":"SHENZHEN, CHINA, Sept.  09, 2026 (GLOBE NEWSWIRE) -- On 9 September, China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS” or the “Group”) is pleased to announce that the initial prescriptions ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358397/0/en/cms-initial-prescriptions-for-silevimig-injection-the-world-s-first-bispecific-antibody-against-rabies-issued-in-china.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNP33.GBP","SG9999015945.SGD","SG9999015952.SGD","IE00BYV24P56.USD","SG9999015986.USD","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","SG9999004311.SGD","IE00BMCWC346.EUR","00867","SG9999015978.USD","LU2488822045.USD","SG9999004220.SGD","BK1593","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458549","title":"Sinopharm Group Stock Slips 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458549?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.1% to 15.70 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.The stock's fall snapped a four-day winning streak.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.2%.Trading volume totaled 5.9 million shares, compared to the 50-day average of 5.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1500","BK0028","BK0196","600196","BK0096","BK1515","BK1197","LU0640798160.USD","LU1115378108.SGD","BK0060","BK0183","BK0188","BK0187","BK1191","BK0175","BK4175","01099","SHTDY","02196","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143782105","title":"UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=1143782105","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143782105?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:03","pubTimestamp":1788940980,"startTime":"0","endTime":"0","summary":"UBS has released a research report indicating that first-half results among Chinese pharmaceutical stocks were mixed, with five of the nine rated companies exceeding market expectations. These...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1521","01177","BK1161","IE00BZ08YS42.EUR","01477","IE00B3M56506.USD","BK1515","IE00BZ08YT58.USD","BK1583","HK0000165453.HKD","01530","BK1574","03933","IE00BZ08YR35.GBP","03692","BK1593","02096","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113076069","title":"HAOHAI BIOTEC (06826) Spends HK$529,300 to Buy Back 31,500 Shares on September 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1113076069","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113076069?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:46","pubTimestamp":1788860773,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (06826) has disclosed that on September 8, 2026, it utilized HK$529,300 to repurchase 31,500 of its own shares.The buyback transaction underscores the company's ongoing capital management strategy and its commitment to enhancing shareholder value through market operations.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665932955","title":"Shanghai Fosun Pharma - Receives Nmpa Approval for Phase Ii/Iii Clinical Trial of Fxs5626","url":"https://stock-news.laohu8.com/highlight/detail?id=2665932955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665932955?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:44","pubTimestamp":1788860689,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN44Z0IU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["600196","02196","BK0096","BK0196","BK0028","BK0239","BK0175","BK1593","BK1515","BK0188","BK0187","BK0012","BK1191","BK0060","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132147233","title":"Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1132147233","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132147233?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:20","pubTimestamp":1788859248,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SH: 600196) has announced that its controlling subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., recently received approval...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","MDTX","BK0183","BK1515","BK1593","IBBQ","BMED","600196","PSYK","BK0060","02196","BK0175","BK0188","BK0028","BK0096","BK0239","BK0196","IBBJ","BK0012","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146341626","title":"Fosun Pharma Spends HK$1.18M on Share Buyback on September 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1146341626","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146341626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:02","pubTimestamp":1788775333,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (HK: 02196) has announced a share repurchase transaction executed on September 7, 2026. According to the company's official disclosure, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0175","BK0196","BK1191","BK1515","600196","BK0183","02196","BK0012","BK0060","BK0096","BK0187","BK0188","BK0028","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665900313","title":"Sinopharm Group Stock Rallies 0.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665900313","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665900313?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:33","pubTimestamp":1788769980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. inched 0.9% higher to 15.83 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's third consecutive day of gains.Sinopharm Group Co. Ltd. closed 29% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 7.1%.Trading volume totaled 4.5 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0183","BK1515","BK1593","600196","BK1197","LU1115378108.SGD","SHTDY","BK0060","02196","LU0640798160.USD","BK0175","BK0188","BK0028","BK0096","BK0239","01099","BK0196","BK0012","BK0187","BK1500","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665992823","title":"Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665992823","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665992823?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:05","pubTimestamp":1788757530,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical , along with its controlling shareholder and subsidiaries, agreed to extend the shareholder loans worth 80.8 million yuan provided to Fuyun Health for another year, according to a Shanghai bourse filing over the weekend.The Chinese pharmaceutical company's Hong Kong shares jumped 7%, while Shanghai shares rose 1% during Monday's midday trade.The loans' extended maturity date will be Sept. 4, 2027, and the annual interest rate during the extension period will remain at 3.2%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK1515","BK1593","BK0096","BK0196","BK0188","BK0187","02196","BK1191","BK0183","BK0175","600196","BK0060","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184969761","title":"AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1184969761","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184969761?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:02","pubTimestamp":1788735760,"startTime":"0","endTime":"0","summary":"The innovative medicine sector is gaining significant momentum as artificial intelligence transforms the drug development landscape from discovery through clinical trials and regulatory approval. A...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","02196","BK4585","BK1141","LNGR","BK1617","BK1574","MEDX","BK1593","VTHR","VXUS","06978","BK4588","AGIX","02228","CHAT","KCAI","AIPO","BK1161","BK1515","QTOC","159992","BK1191","IBBQ","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364504","title":"Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364504","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364504?lang=en_us&edition=fundamental","pubTime":"2026-09-06 18:34","pubTimestamp":1788690846,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260906:nL6N44Y02K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0175","BK0096","BK1191","BK0012","BK0196","02196","BK0188","BK0183","BK0060","BK0028","600196","BK1515","BK1593","BK0187","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120592433","title":"Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1120592433","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120592433?lang=en_us&edition=fundamental","pubTime":"2026-09-06 17:04","pubTimestamp":1788685454,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) has announced that its controlling subsidiary, Fosun Pharma Singapore, executed a share sale of Gland Pharma shares on September 4, 2026...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK0060","BK0196","BK0239","BK0187","BK1515","02196","BK0028","BK0188","BK0175","BK0012","BK0183","BK1191","600196","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339079","title":"Sisram Medical Declares HKD 0.095 Final Dividend for Fy2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339079","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339079?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:53","pubTimestamp":1788522800,"startTime":"0","endTime":"0","summary":"Sisram Medical declares HKD 0.095 final dividend for FY2025Sisram Medical declared a final dividend of HKD 0.095 per share for the year ended Dec. 31, 2025.Shares trade ex-dividend on Aug. 26, 2026.Re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL8TGg3k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","00656","BK1585","01696","BK1230","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803133","title":"Sinopharm Group Stock Advances 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803133?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:33","pubTimestamp":1788510780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 1.5% to 15.69 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.4%.Trading volume totaled 9.2 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196","BK0060","BK0175","BK0012","BK0183","BK4175","BK1191","BK0188","BK1197","BK0187","BK0239","BK1515","01099","BK1593","BK0096","BK0028","LU1115378108.SGD","LU0640798160.USD","SHTDY","BK1500","600196","BK0196"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":64,"code":"91000000","status":"200"}]}}